Angene Chemical
Draw
|
Currency :
Home Products

AG0034T4

24390-14-5 | 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol, hydrate (2:2:1:1)

Chemical structure of 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol, hydrate (2:2:1:1), CAS 24390-14-5
AG0034T4
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 24390-14-5
Catalog Number AG0034T4(AGN-PC-0R078P)
Chemical Name 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol, hydrate (2:2:1:1)
EC Number 607-368-7
IUPAC Name (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
InChI InChI=1S/2C22H24N2O8.C2H6O.2ClH.H2O/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;1-2-3;;;/h2*4-7,10,14-15,17,25-27,30,32H,1-3H3,(H2,23,31);3H,2H2,1H3;2*1H;1H2/t2*7-,10+,14+,15-,17-,22-;;;;/m00..../s1
InChI Key UHHHTIKWXBRCLT-VDBOFHIQSA-N
MDL Number MFCD17018844
Molecular Formula C46H58Cl2N4O18
Molecular Weight 1025.8747
SMILES O.C(C)O.Cl.CN([C@@H]1C(=C(C([C@]2(C(=C3C(C4=C(C=CC=C4[C@@H]([C@H]3[C@@H]([C@@H]12)O)C)O)=O)O)O)=O)C(=O)N)O)C.CN(C)[C@@H]1C(=C(C([C@]2(C(=C3C(C4=C(C=CC=C4[C@@H]([C@H]3[C@@H]([C@@H]12)O)C)O)=O)O)O)=O)C(=O)N)O.Cl
UNII 19XTS3T51U
Synonyms
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-, alpha 6 Deoxyoxytetracycline, alpha-6-Deoxyoxytetracycline, Atridox, BMY 28689, BMY-28689, BMY28689, BU 3839T, BU-3839T, BU3839T, Doryx, Doxycycline, Doxycycline Calcium, Doxycycline Calcium Salt (1:2), Doxycycline Chinoin, doxycycline hemiethanolate, doxycycline hyclate, Doxycycline Monohydrate, Doxycycline Monohydrochloride, 6 epimer, Doxycycline Monohydrochloride, 6-epimer, Doxycycline Monohydrochloride, Dihydrate, Doxycycline Phosphate (1:1), Doxycycline-Chinoin, Hydramycin, Oracea, Periostat, Vibra Tabs, Vibra-Tabs, Vibramycin, Vibramycin Novum, Vibravenos, Doxycycline hyclate, 24390-14-5, Vivox, Doxy-Lemmon, Doxychel Hyclate, Atridox, Periostat, Doryx, Doxy 100, UNII-19XTS3T51U, Roximycin, DOXY 200, Doxycycline hydrochloride hemiethanolate hemihydrate, Vibramycin hyclate, Doxycycline hyclate (internal use), DOXY, 19XTS3T51U, Hydramycin, 6-Deoxy-5-hydroxytetracycline hydrochloride hemihydrate, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, compound with ethyl alcohol (2:1), monohydrate, Tetraclean, Acticlate, Dentista, Doxteric, Doxyprex, Monodoks, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, compd. with ethanol (2:1), monohydrate, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-, 2-Naphthacenecarboxamide, 4beta-(dimeethylamino)-1,4,4abeta,5,5abeta,6,11,12a-octahydro-3,5beta,10,12,12abeta-pentahydroxy-6beta-methyl-1,11-dioxo-, monohydrochloride, compd. with ethyl alcohol (2:1), monohydrate, Ethanol, compd. with (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2), monohydrate, MFCD07357237, 10592-13-9 (. HCl), Acticlate CAP, Doryx Mpc, Doxycycline hyclate [USAN:USP], doxycycline-hyclate, Periostat (TN), (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride, Vibra-tabs (TN), Doryx (TN), WC 2031, AC1NQZPV, DOXYCYCLINE HYLATE, AC1NUYS5, Doxycycline hyclate (USP), Doxycycline Hyclate (100 mg), CHEMBL3989740, DTXSID4041020, (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide compound with ethanol (2:1) dihydrochloride hydrate, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol, hydrate (2:2:1:1), 2387AH, WC2031, AKOS025402170, doxycycline hyclate 20 mg twice daily, 2C22H24N2O8.C2H6O.H2O, AC-6017, DS-9077, AN-18097, Doxycycline hydrochloride hydrate (JP17), 2C22H24N2O8.C2H6O.2ClH.H2O, LS-174052, SW219440-1, SW219440-2, D02129, Z2791720087, (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; ethanol; hydrate; dihydrochloride, (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; ethanol; hydrate; dihydrochloride, (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; ethanol; hydrate; dihydrochloride, (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide - ethanol (2:1) dihydrochloride hydrate, bis((4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide) ethanol hydrate dihydrochloride, Vibramycin, Vibra-tabs, Biocamycin, doxycycline, Doxigalumicina, Idocyklin, Liomycin, Mespafin, Nivocilin, Tanamicin, Tetradox, Vibradox, Doxylin, Midoxin, Novadox, Samecin, Soludox, Tecacin, Ecodox, Doxy-tablinen, Doxy-II, RETENS, Vibramycin hydrochloride, Doxycycline hydrochloride, Doxycycline Hyclate [USAN], C22H24N2O8.ClH, UNII-4182Z6T2ET, Doxycycline Hydrochloride [JAN], Deoxyoxytetracycline hydrochloride, e-64, C22-H24-N2-O8.Cl-H, EINECS 234-198-7, Doxycycline hyclate, 95% - 5G 5g, CID5282244, CID5463942, Deoxy-5-hydroxytetracycline hydrochloride, C22H24N2O8.ClH.1/2C2H6O.H2O, 6-Desoxy-5-hydroxytetracycline hydrochloride, alpha-6-Deoxy-5-hydroxytetracycline hydrochloride, C22-H24-N2-O8.Cl-H.1/2C2-H6-O.H2-O, 10592-13-9, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a, 5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy -6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol (2:1), mono, 2-naftacencarboxamida, 4-(dimetilamino)-1,4,4a,5,5a,6,11,12a-octahidro-3,5,10,12,12a-pentahidroxi-6-metil-1,11-dioxo-, clorhidrato (1:1), (4s,4ar,5s,5ar,6r,12as)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a, 5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy -6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.alpha.,12a.alpha.)]-, monohydrochloride, hemihydrate, compd. with ethanol (2:1), 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol (2:1), monohydrate, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.alpha.,12a.alpha.)]-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.alpha.,12a.alpha.)]-, compd. with ethanol (2:1), monohydrate, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha)]-, 2-Naphthacenecarboxamide, 4.beta.-(dimethylamino)-1,4,4a.beta.,5,5a.beta.,6,11,12a-octahydro-3,5.beta.,10,12,12a.beta.-pentahydroxy-6.beta.-methyl-1,11-dioxo-, monohydrochloride, compd. with ethyl alc. (2:1), monohydrate, 564-25-0, Ethanol, compd. with (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited